Rivaroxaban-Treated AF Patients with Prior Stroke and TIA Confirming RCT Data in the Real World
Rivaroxaban-Treated AF Patients with Prior Stroke and TIA Confirming RCT Data in the Real World
2021-02-17
Prof. Danilo Toni discusses findings from the RE-AFFIRM study for patients with prior stroke treated with Rivaroxaban vs. Warfarin in clinical routine and puts the data from the randomized controlled trial ROCKET AF into perspective
© Bayer AG, 2020 | Approval number PP-XAR-ALL-1767-1
Copyright © Bayer AG |
Updated date 10/10/2022
This website is intended to provide information to an
international audience outside the USA and UK.
